$70.035
-0.425[-0.60%]
Last update: 11:33AM Get Real Time Here
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
02/27/2024 | LGND | Ligand Pharmaceuticals | FY | 2024 | $4.25 | $4.75 | $4.27 | $130.00M | $142.00M | $138.50M | Get Alert |
12/12/2023 | LGND | Ligand Pharmaceuticals | FY | 2024 | $4.25 | $4.75 | $4.17 | $130.00M | $142.00M | $138.60M | Get Alert |
12/12/2023 | LGND | Ligand Pharmaceuticals | FY | 2028 | $10.00 | $10.50 | — | — | — | — | Get Alert |
11/08/2023 | LGND | Ligand Pharmaceuticals | FY | 2023 | $5.25 | $5.40 | $5.01 | $126.00M | $129.00M | $126.50M | Get Alert |
09/18/2023 | LGND | Ligand Pharmaceuticals | FY | 2023 | $5.10 | $5.25 | $4.98 | $124.00M | $126.00M | $127.05M | Get Alert |
08/08/2023 | LGND | Ligand Pharmaceuticals | FY | 2023 | $4.85 | $5.00 | $4.63 | $124.00M | $128.00M | $131.17M | Get Alert |
05/04/2023 | LGND | Ligand Pharmaceuticals | FY | 2023 | $4.60 | $4.75 | $3.52 | $124.00M | $128.00M | $128.57M | Get Alert |
02/22/2023 | LGND | Ligand Pharmaceuticals | FY | 2023 | $3.30 | $3.45 | $3.24 | $120.00M | $124.00M | $130.58M | Get Alert |
12/13/2022 | LGND | Ligand Pharmaceuticals | FY | 2022 | $4.30 | $4.45 | $4.24 | $184.00M | $189.00M | $212.82M | Get Alert |
12/13/2022 | LGND | Ligand Pharmaceuticals | FY | 2023 | $3.10 | $3.30 | $2.99 | $118.00M | $122.00M | $136.50M | Get Alert |
11/07/2022 | LGND | Ligand Pharmaceuticals | FY | 2022 | $4.30 | $4.45 | $2.79 | $184.00M | $189.00M | $181.56M | Get Alert |
08/08/2022 | LGND | Ligand Pharmaceuticals | FY | 2022 | $2.40 | $3.00 | $2.30 | $169.00M | $188.00M | $162.86M | Get Alert |
05/04/2022 | LGND | Ligand Pharmaceuticals | FY | 2022 | $1.70 | $2.20 | $3.22 | $147.00M | $172.00M | $162.39M | Get Alert |
02/17/2022 | LGND | Ligand Pharmaceuticals | FY | 2022 | — | — | — | $147.00M | $172.00M | $189.91M | Get Alert |
11/09/2021 | LGND | Ligand Pharmaceuticals | FY | 2021 | $5.80 | $6.05 | $5.93 | $265.00M | $275.00M | $270.82M | Get Alert |
07/29/2021 | LGND | Ligand Pharmaceuticals | FY | 2021 | $5.80 | $6.05 | $6.12 | $265.00M | $275.00M | $280.44M | Get Alert |
05/03/2021 | LGND | Ligand Pharmaceuticals | FY | 2021 | $6.15 | $6.15 | $6.17 | $291.00M | $291.00M | $291.62M | Get Alert |
02/03/2021 | LGND | Ligand Pharmaceuticals | FY | 2021 | $6.15 | $6.15 | $6.09 | $291.00M | $291.00M | $289.00M | Get Alert |
10/30/2020 | LGND | Ligand Pharmaceuticals | FY | 2021 | $6.00 | $6.00 | $5.89 | $285.00M | $285.00M | $276.96M | Get Alert |
The last reported Earnings numbers were from February 27, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $4.25 and $4.75 versus the estimated EPS of $4.27.
Browse guidance and forecast on all stocks.